ABBOTT PARK, Ill., Oct. 13 Abbott's board ofdirectors has authorized the repurchase of up to $5 billion of thecorporation's common stock.
The purchases may be made from time to time as market conditions warrantand subject to regulatory considerations. The timing and amounts of anypurchases will be determined by the company's management. The sharerepurchase authorization has no time limit and may be discontinued at anytime.
Abbott (NYSE: ABT) is a global, broad-based health care company devoted tothe discovery, development, manufacture and marketing of pharmaceuticals andmedical products, including nutritionals, devices and diagnostics. Thecompany employs more than 68,000 people and markets its products in more than130 countries.
Abbott's news releases and other information are available on thecompany's Web site at http://www.abbott.com.